ABSTRACT The residual efÞcacy of pyriproxyfen against Aedes aegypti (L.) was examined by treating 2-liter buckets with a range of rates of Sumilarv 0.5G (100, 10, 1, and 0.1 mg product/liter or nominal dose of 500, 50, 5, and 0.5 ppb active ingredient) under semiÞeld conditions. Approximately every 2 wk, pupal emergence inhibition (EI) was measured by using Cairns colony Ae. aegypti. Pooled water samples from the Þve replicate buckets were analyzed for active pyriproxyfen by using ultra-high-pressure liquid chromatography with tandem mass spectrometry detection. A strong doseÐ response in EI was exhibited, with the 0.1 mg/liter giving Ϸ50% EI for only the initial week, whereas the 10 and 100 mg/liter doses produced EI Ͼ 90% for 8 and 40 wk, respectively. Measurable levels of active ingredient were detected in the 100, 10, and 1 mg/liter treatments, with measured starting concentrations of just 1Ð2Ð1.4% of the delivered (active ingredient) dose. Pyriproxyfen was detected in the 100 mg/liter treatment through the entire course of the trial (60 wk).
In northern Australia, vector control ofÞcers require residual treatment of containers, as they cannot revisit properties at Ͻ1-mo intervals during large-scale dengue control programs. The current Aedes albopictus (Skuse) eradication program in the Torres Strait of Australia uses vector control tours at 6 Ð 8-wk intervals and requires residual treatment of containers. To date, larval control consists of treatment of containers with s-methoprene pellets or surface spray with residual synthetic pyrethroid such as bifenthrin. The synthetic pyrethroids can have nontarget effects and are vulnerable to degradation by ultraviolet light outdoors. High "megadoses" of Bti granules have also been used to provide residual control (Ritchie et al. 2010) .
The insect growth regulator pyriproxyfen has excellent potential for the residual control of mosquitoes such as Aedes aegypti and Ae. albopictus. Pyriproxyfen works effectively at very low doses (Invest and Lucas 2008 , Devine et al. 2009 , Webb et al. 2012 ). In the Þeld, Sihuincha et al. (2005) obtained Ͼ90% control of Ae. aegypti in water tanks for up to 5 mo by using doses of just 50 Ð 83 ppb. Vythilingham et al. (2005) obtained 4 Ð5 mo residual control of Ae. aegypti in 50-liter earthen jars with even lower doses (10 Ð20 ppb), and Chang et al. (2006) suppressed adult emergence from water storage jars for at least 6 mo by using a resinbased slow-release formulation of pyriproxyfen.
Use of gravid mosquitoes to "auto-disseminate" minute doses of pyriproxyfen has been developed as a strategy to control container-breeding mosquitoes (Itoh et al. 1994 , Sihuincha et al. 2005 , Devine et al. 2009 ). Devine et al. (2009) obtained control of Ae. aegypti by auto-dissemination to adjoining breeding sites of an estimated dose as small as 0.012 ppb active ingredient (AI). In North Queensland, Aedes-breeding sites are often small, holding Ͻ5 liters of water, and the granular formulation of pyriproxyfen (Sumilarv 0.5 G) offers potential not only for control of Ae. aegypti breeding but also auto-dissemination of active ingredient from these sentinel breeding sites to adjoining untreated sites. In this trial, we measured the efÞcacy of Sumilarv 0.5 G against Ae. aegypti in small containers in a semiÞeld cage in Cairns, Queensland, over a 60-wk period.
Materials and Methods
Impact of Pyriproxyfen Against Ae. aegypti Under Semifield Conditions. Ae. aegypti larvae were exposed to four different doses of pyriproxyfen in 2-liter white plastic buckets under semiÞeld conditions. Treatment doses of Sumilarv 0.5 G were 0.2, 0.02, 0.002, and 0.0002 g product/2-liter bucket (or 100, 10, 1, 0.1 mg product/ liter) yielding nominal concentrations of 500, 50, 5, and 0.5 g (AI)/liter (ppb) of pyriproxyfen, respectively. An untreated bucket served as a control. Five buckets (one from each treatment group and the control) were placed inside Þve plastic trays that were set inside a screened 5 by 7 by 4-m semiÞeld cage to prevent oviposition from wild Ae. aegypti that might confound results, and to protect the buckets from direct sunlight that could degrade the active ingredient. The semiÞeld cage was covered with 90% shade cloth awning that produced a total shade of 99%. However, rainfall could penetrate the shade cloth, and overßowing and water turnover occurred in the buckets but was not measured. Fortnightly, 20 third-instar Ae. aegypti (Cairns colony F3Ð10) were added to each bucket, with 0.5 g of Friskies cat food pellet (NestleÕs Purina Petcare, Blayney, NSW, Australia) added for food when needed. Twice each week, pupae were collected by pipette and placed into 70-ml plastic jars containing tap water for emergence. For the highest dose, assessment periods were extended to 4 wk after 30-wk assessment. The trial was run for 60 wk or until control (emergence inhibition or EI) (The terms control and emergence inhibition may be used interchangeably) was Ͻ50% for a given treatment.
Meteorological data were obtained for the Cairns Airport site (10 km SE of the semiÞeld cage) from the Australian Bureau of Meteorology. The buckets were exposed to heavy rainfall, with 2,596 ml of rainfall recorded at the Cairns Airport during the exposure period. The mean minimum and maximum temperature during the trial was 20.3 and 28.9ЊC, respectively.
Measurement of Pyriproxyfen in Treatment Buckets. Five 1-ml samples were extracted from each bucket weekly using a 1-ml pipette from each of the Þve buckets. The Þve samples for each treatment were pooled for subsequent analysis. Water samples were supplied to ACS Laboratories (Australia) (Kensington, Victoria) for analysis of pyriproxyfen content in August 2012. Each sample was diluted 1:1 with acetonitrile and then Þltered through a 0.2-m Teßon syringe Þlter into a 2-ml glass vial. Two microliters of the diluted sample was then injected onto a Waters BEH C18 column (1.7 m, 50 by 2.1 mm) using a Waters Aquity UPLC-MS-MS (ultra-high-pressure liquid chromatography with tandem mass spectrometry detection). Pyriproxyfen was eluted with a mixture of acetonitrile and 5 mM trißuoroacetic acid (75: 25) at 0.5 ml/min and quantiÞed by external calibration. Limit of detection was 0.05 ppb.
Statistical Analysis. An analysis of variance (ANOVA) was used to compare mean adult emergence between the treatments. The lack of replication created by pooling the water samples prevented us from conducting a similar comparison on the pyriproxyfen detected in the buckets.
Results

Impact of Pyriproxyfen Against
Ae. aegypti Under Semifield Conditions. A clear doseÐresponse was noted in the efÞcacy of Sumilarv 0.5G against Ae. aegypti. The very lowest dose (0.1 mg/liter) provided Ϸ50% control for the initial week before rapidly tailing off. The 10-mg/liter dose gave good control for 8 Ð10 wk. The highest dose (100 mg/liter) provided Ͼ95% control for 40 wk, with the exception of slightly higher emergence at 2 and 8 wk (88 and 94% EI, respectively). After 40 wk, control gradually declined to 60% at the conclusion of the trial. An ANOVA was conducted on mean EI for the initial 14 wk of treatment, after which only the high dose maintained any level of control (Fig. 1) . There was a signiÞcant interaction between treatment group and weeks posttreatment (F(24, 140) ϭ 12.41; P Ͻ 0.0001), as well as a signiÞcant effect of "treatment group" (F(4, 140) ϭ 269.1; P Ͻ 0.0001) and a signiÞcant effect of "weeks posttreatment" (F(6, 140) ϭ 39.48; P Ͻ 0.0001).
Detection of Pyriproxyfen in Treated Water. Levels of pyriproxyfen declined steadily in the treated buckets (Table 1) and was dose dependent. After wk 2, pyriproxyfen was only detected in the highest dose (100 mg/liter). No active ingredient was detected in the smallest dose (0.1 mg/liter) at any time, and concentrations in water for the 1-and 10-mg/liter doses fell below the limit of detection after 2 wk and 1 wk posttreatment, respectively. Pyriproxyfen was detected for 60 wk for the highest treatment dose of 100 mg /liter, but levels in the bucket water rapidly declined to Ͻ1 ppb by 12 wk (Fig. 1) . 
Discussion
These data indicate that Sumilarv granules can provide persistent control of Ae. aegypti under simulated Þeld conditions. Both control and detection of (AI) in water samples were strongly dose dependent. The minimum dose, 0.1 mg/liter (or the equivalent of a single Sumilarv granule/bucket), even provided brief control for 2 wk, with increasing levels of control and residuality for the higher doses. The highest dose (100 mg/liter) provided Ͼ85% control for the entire study and Ͼ95% for all but two sample periods (88 and 94% at wk 2 and 8, respectively). High doses of Sumilarv could be used to provide very long residual control of Aedes in typical small breeding sites such as water storage containers, tires, sump pits, and other small water reservoirs that might serve as breeding sites. We acknowledge that the exposure of treated buckets was conducted under semiÞeld conditions that may not reßect conditions in the Þeld, particularly exposure to ultraviolet light, detritus, and rainfall. Additional studies of pyriproxyfen persistence should be conducted under a range of Þeld conditions.
The persistence of active pyriproxyfen within treated buckets shows that active ingredient is slowly released into the water. The initial highest dose (100 mg/liter) was sufÞcient to create a concentration of 500 ppb of pyriproxyfen. However, we detected a concentration of only 7.5 ppb at wk 1, just 1.4% of the total (AI) dose. This was consistent for the lower doses too, with residual pyriproxyfen detected in water at wk 1 representing just 1.2 and 1.4% of the total doses applied for the 50 and 5 ppb treatments, respectively. Webb et al. (2011) reported initial levels of pyriproxyfen in water of Ϸ7 ppb, after application of a liquid formulation at a nominal rate of just 7 ppb, and this declined to Ͻ1 ppb within 5Ð7 d. In liquid form, the pyriproxyfen is freely available in solution initially, whereas the granular application releases only small amounts of pyriproxyfen over a longer period, making it more suitable for long-term residual control. A limitation of the study is that a single pooled water sample was used for analysis, effectively eliminating any replication.
Temporary control in breeding sites, even using very low doses for short periods, could be used to reduce wild populations of Ae. aegypti to enhance establishment of Wolbachia in open-Þeld releases (Hancock et al. 2011 , Hoffmann et al. 2011 . Field workers have used bleach to provide short-term control of Ae. aegypti in breeding sites as part of a "crash and release" strategy (Jacups et al. 2013) . However, the auto-dissemination of pyriproxyfen, either as a dust or dissolved in water, could be used to treat cryptic and inaccessible breeding sites such as septic tanks and roof gutters. Contaminated mosquitoes could be used to transfer effective doses of pyriproxyfen to such sites (Devine et al. 2009 , Caputo et al. 2012 , Gaugler et al. 2012 . Devine et al. (2009) demonstrated that adult Ae. aegypti could be captured in traps where they pick up minute dust particles containing pyriproxyfen that are then disseminated to breeding sites by the mosquito. The dose data from Table 1 could also be used to estimate longevity of control based on the dose of pyriproxyfen and amount of (AI) in the water. This could be useful for estimating the timing of auto-dissemination treatment and release of Wolbachia-infected mosquitoes to avoid killing offspring of released mosquitoes. 
